References
- Nichol KL, Lind A, Margolis KL et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med. 333(14), 889–893 (1995).
- Tang DC, Zhang J, Toro H, Shi Z, Van Kampen KR. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert Rev. Vaccines 8(4), 469–481 (2009).
- Zhang J, Tarbet EB, Toro H, Tang DC. Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases. Expert Rev. Vaccines 10(11), 1539–1552 (2011).
- Bodewes R, Fraaij PL, Geelhoed-Mieras MM et al. Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children. J. Virol. 85(22), 11995–12000 (2011).
- Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20(25–26), 3068–3087 (2002).
- Victor ST, Watanabe S, Katsura H, Ozawa M, Kawaoka Y. A replication-incompetent PB2-knockout influenza A virus vaccine vector. J. Virol. 86(8), 4123–4128 (2012).
- Neumann G, Watanabe T, Ito H et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96(16), 9345–9350 (1999).
- Zhou B, Li Y, Belser JA et al. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine 28(50), 8015–8025 (2010).
- Watanabe T, Watanabe S, Neumann G, Kida H, Kawaoka Y. Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J. Virol. 76(2), 767–773 (2002).
- Mueller S, Coleman JR, Papamichail D et al. Live attenuated influenza virus vaccines by computer-aided rational design. Nat. Biotechnol. 28(7), 723–726 (2010).
- Zhang J, Tarbet EB, Feng T, Shi Z, Van Kampen KR, Tang DC. Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza. PLoS ONE 6(7), e22605 (2011).
- Seo SU, Lee KH, Byun YH, Kweon MN, Seong BL. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine. Vaccine 25(47), 8067–8076 (2007).